Business Daily Media

Business Marketing

.

Eisai: New Drug Application for In-House Developed New Anti-insomnia Drug Dayvigo Accepted in Hong Kong

  • Written by ACN Newswire - Press Releases

Eisai: New Drug Application for In-House Developed New Anti-insomnia Drug Dayvigo Accepted in Hong Kong

TOKYO, Jul 8, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that the new drug application for approval of its in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, has been

Read more //?#

Popular

Jollibee Group Brings 11-Year Michelin-starred Tim Ho Wan to Mainland China

SINGAPORE - The Jollibee Group opened Mainland China's first-ever Tim Ho Wan in Shanghai on September 23, Wednesday, marking the Michelin starred restaurant's entry into one of the world's largest economies. Located in the Jin...

How to Communicate Cyber Risk to the Board

While today’s digitally-connected world has elevated the global economy to new heights, one cannot ignore the fact that cyberattacks and data breaches have also become a frequent problem. Research has shown that cyberattacks a...

Stake Appoints New CEO

Jon Howie promoted to the role of CEO after a comprehensive selection process driven by Stake’s founders Stake, the Australian investment platform, has appointed Jon Howie to the role of CEO, to lead the business into its next...

Virtual Office
Tomorrow Business Growth